$XFOR Cashflow Statement | Understand Stock

$XFOR

$3.25 +$0.00 (0.0%) Close

$XFOR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation and amortization expense
Goodwill impairment
Gain on sale of non-financial asset
Non-cash lease expense
Accretion of debt discount
Loss on extinguishment of debt
Change in fair value of warrant liability
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses, other current and non-current assets and research and development incentive receivable
Accounts payable
Accrued expenses and other long-term liabilities
Deferred revenue
Lease liabilities
Operating lease right-of-use asset, net of non-cash portion

Net cash used in operating activities
Cash flows from investing activities:
Cash, cash equivalents and restricted cash acquired in connection with the Merger
Acquisition of intangible asset
Proceeds from sale of non-financial asset
Purchase of marketable securities
Sales and maturities of marketable securities
Acquisition of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from exercise of stock options, warrants, and pre-funded warrants and issuance of shares of common stock under employee stock purchase plan
Proceeds from borrowings under loan and security agreement
Repayments of borrowings under loan and security agreement
Payments for Repurchase of Common Stock
Issuance costs for amendments to loan and security agreement and for the sale of warrants accounted as a liability
Employee taxes paid related to net share settlement of vested restricted stock units
Proceeds from sale of shares of common stock, warrants and pre-funded warrants, less issuance costs
Net cash provided by financing activities
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Acquisition of intangible assets included in accrued expenses
Cash paid for interest
Lease Obligation Incurred
Issuance costs not yet paid
Conversion of convertible preferred stock into common stock
Conversion of redeemable common stock into common stock
Conversion of convertible preferred stock warrants into common stock warrants
Fair value of net assets acquired in the Merger in exchange for common shares, excluding cash acquired

Comments